Servier Information

We are an international pharmaceutical company, governed by a non-profit foundation based in France (Suresnes). With a strong international presence in 148 countries and a turnover of 4,152 billion euros in 2017, we have a workforce of 21,600 employees worldwide. Totally independent, we reinvest 25% of our revenues (excluding generic drugs) in R&D and use all our profits for development. Corporate growth is driven by our constant pursuit of innovation in 5 areas of excellence: cardiovascular disease, immuno-inflammatory and neuropsychiatric diseases, cancer and diabetes, as well as our activities in high quality generic drugs. We currently have 35 candidate drug molecules, including 22 new molecular entities at various stages of clinical development. Our priorities are pathologies with high medical needs within our areas of expertise. To report an adverse reaction with one of our products, please visit our website servier.com.br